Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
CHANDLER, Ariz., May 02, 2024 (GLOBE NEWSWIRE) -- Microchip Technology (Nasdaq: MCHP) today announces that registration is now open for its signature Worldwide MASTERs Conference, the premier...
-
Plans to Introduce the Myseum Media Archiving & Social Networking Platform New Brunswick, NJ, May 01, 2024 (GLOBE NEWSWIRE) -- DatChat (Nasdaq: DATS), a secure messaging, social media, and...
-
BOSTON and ROLLE, Switzerland, April 30, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced that Chief Financial Officer...
-
– New Evidence Indicates ATH434 can Function as an Iron Chaperone to Redistribute Iron – MELBOURNE, Australia and SAN FRANCISCO, April 29, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX:...
-
Code42 team to host conversations about how to mitigate data loss and protect source code without hindering productivity or burdening security teams.
-
Irvine, California, April 23, 2024 (GLOBE NEWSWIRE) -- Origence, the leading lending technology solutions provider for credit unions, announces breakout session speakers for its Lending Tech Live...
-
Littleton, NH, April 22, 2024 (GLOBE NEWSWIRE) -- Over 150 Community Health Workers (CHWs), healthcare providers, social workers, policymakers, and state agencies will come together on April 30,...
-
NurExone Presenting on Revolutionary Spinal Cord Injury Therapy at top European Conference on Exosomes and Regenerative Medicine
-
FII Institute is excited to announce the theme for its upcoming 8th edition of the FII conference, scheduled for October 29-31, 2024.
-
– ATH434 Improved Motor Performance and General Function in a Primate Model of Parkinson’s Disease – – ATH434-201 Phase 2 Baseline Data Confirm Approach to Target Biomarkers for Slowing...